Drugs / EchiTabPlus-ICP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02694952 | Mar → Jun 2016 | snakebite envenomation | Epicentre | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EchiTabPlus-ICP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02694952 ↗ |
| Modality | Protein / enzyme biologic | “Polyspecific antivenom immunoglobulin of equine origin manufactured by the Clodomiro Picado Institute, San Jose, Costa Rica.” NCT02694952 ↗ |